Telehealth for patients with hypertension, coronary artery disease or implantable cardiac devices a review of the clinical effectiveness, cost-effectiveness and guidelines
This Rapid Response report aims to review the clinical- and cost-effectiveness of telehealth for patients with hypertension, coronary artery disease (CAD), or conditions requiring implantable cardiac devices. Guidelines associated with the use of telehealth in the management of these conditions will...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Ottawa, Ontario]
Canadian Agency for Drugs and Technologies in Health
2016, 27 January 2016
|
| Series: | Rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This Rapid Response report aims to review the clinical- and cost-effectiveness of telehealth for patients with hypertension, coronary artery disease (CAD), or conditions requiring implantable cardiac devices. Guidelines associated with the use of telehealth in the management of these conditions will also be examined |
|---|---|
| Physical Description: | 1 PDF file (28 pages) illustrations |